Overview
Zefeng Xu practices in Tianjin, China. Xu is rated as a Distinguished expert by MediFind in the treatment of Essential Thrombocythemia. Their top areas of expertise are Myelofibrosis, Myelodysplastic Syndrome (MDS), Polycythemia Vera, and Splenomegaly.
Their clinical research consists of co-authoring 132 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 7 articles in the study of Essential Thrombocythemia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Essential ThrombocythemiaXu isDistinguished. Learn about Essential Thrombocythemia.
- Myelodysplastic Syndrome (MDS)
- MyelofibrosisXu isDistinguished. Learn about Myelofibrosis.
- Myeloproliferative Neoplasms (MPN)
- Polycythemia VeraXu isDistinguished. Learn about Polycythemia Vera.
- SplenomegalyXu isDistinguished. Learn about Splenomegaly.
- Advanced
- Blood ClotsXu isAdvanced. Learn about Blood Clots.
- Hypereosinophilic Syndrome
- LeukemiaXu isAdvanced. Learn about Leukemia.
- Philadelphia-Negative Chronic Myeloid Leukemia
- Experienced
- Acute Myeloid Leukemia (AML)
- ADULT SyndromeXu isExperienced. Learn about ADULT Syndrome.
- AnemiaXu isExperienced. Learn about Anemia.
- Chromosome 7p DeletionXu isExperienced. Learn about Chromosome 7p Deletion.
- Chronic Myelogenous Leukemia (CML)
- Chronic Myelomonocytic Leukemia (CMML)